23andMe, the personal genetics company which previously raised $50 million in a Series D round of funding, has closed the round at $58 million. Backers include Yuri Milner as well as Sergey Brin, 23andMe CEO Anne Wojcicki, New Enterprise Associates, Google Ventures and MPM Capital. [Source: Fortune Term Sheet]